Growth after recombinant human growth hormone (rhGH) treatment in transplanted thalassemic patients

Bone Marrow Transplantation

Volumn 20, Issue 7, 1997, Pages 567-573

  De Simone, M ^a,d   Di Bartolomeo, P ^b   Olioso, P ^b   Di Girolamo, G ^b   Palumbo, M ^a   Farello, G ^a   Aconito, P ^c   Papalinetti, G ^b   Bavaro, P ^b   Criscione, S ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c Serono Pharma SpA   (Italy)

^d Universita' Coppito II   (Italy)

Author keywords

Bone marrow transplantation; Growth; Recombinant human growth hormone; Thalassemia major

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FERRITIN BLOOD LEVEL; GROWTH HORMONE RELEASE; GROWTH RATE; HORMONE BLOOD LEVEL; HUMAN; LIVER INJURY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION; THALASSEMIA MAJOR; TREATMENT OUTCOME;

EID: 0030667212     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700931     Document Type: Article

References (28)

1. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 292: 832-843.
2. Di Bartolomeo P, Di Girolamo G, Angrilli F et al. Treatment of thalassemia by allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12 (Suppl. 1): 37-41.
3. Tanner JM. The Physique of the Olympic Athlete. George Allen and Unwin: London, 1964.
4. Tanner JM, Whitehouse RH, Marshall WA et al. Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 method). Academic Press: 1975.
5. Tanner JM, Whitehouse RH. Clinical longitudinal standard for height, weight, height velocity and weight velocity and the stages of puberty. Arch Dis Child 1976; 51: 170-179.
6. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with Greulich-Pyle hand standards. J Pediatr 1952; 40: 423-444.
7. Canale VC, Steinherz P, New MI et al. Endocrine function in thalassemia major. Ann NY Acad Sci 1974; 232: 333-339.
8. Flynn DM, Fairney A, Jackson D et al. Hormonal changes in thalassemia major. Arch Dis Child 1976; 51: 828-836.
9. McIntosh N. Endocrinopathy in thalassemia major. Arch Dis Child 1976; 51: 195-198.
10. Economidou J. Problems related to treatment of β thalassemia major. Pediatrician 1982; 11: 157-161.
11. Borgna-Pignatti C, De Stefano P, Zonta L et al. Growth and sexual maturation in thalassemia major. J Pediatr 1985; 106: 150-155.
12. De Sanctis V, Vullo C, Katz M et al. Gonadal function in patients with thalassemia major. J Clin Pathol 1988; 41: 133-137.
13. Kattamis C, Liakopoulou T, Kattamis A. Growth and development in children with thalassemia major. Acta Pediatr Scand 1990; 366(Suppl.) 111-117.
14. Baker HWG, Burger H, De Kretser DM. A study of the endocrine manifestation of hepatic cirrhosis. Q J Med 1976; 45: 145-149.
15. Saenger P, Schwartz E, Markenson HL et al. Depressed serum somatomedin activity in β-thalassemia. J Pediatr 1980; 96: 214-218.
16. Lucarelli G, Galimberti M, Polchi P et al. Bone marrow transplantation in patients with thalassemia. New Engl J Med 1990; 322: 417-421.
17. Borgna-Pignatti C. Bone marrow transplantation for the hemoglobinopathies. In: Treleaven J, Barret J, Gale RP (eds). Bone Marrow Transplantation in Practice. Churchill-Livingstone: London, 1992, pp 151-159.
18. Lassman MN, O'Brien RT, Pearson HER et al. Endocrine evaluation in thalassemia major. Ann NY Acad Sci 1974; 232: 236-237.
19. Masala A, Meloni T Galisia D et al. Endocrine functioning in multitransfused prepubertal patients with homozygous β thalassemia. J Clin Endocrinol Metab 1984; 58: 667-670.
20. Leger J, Girot R, Crosnier H et al. Normal growth hormone (GH) response to GH-releasing hormone in children with thalassemia major before puberty: a possible age-related effect. J Clin Endocrinol Metab 1989; 69; 453-455.
21. Pintor C, Cella S, Manso P et al. Impaired growth hormone (GH) response to GH-releasing hormone on thalassemia major. J Clin Endocrinol Metab 1986; 6: 263-267.
22. Leheup BP, Cisternino M, Bozzola M et al. Growth hormone response following growth hormone releasing hormone injection in thalassemia major: influence of pubertal development. J Endocrinol Invest 1991; 14: 37-40.
23. De Luca G, Maggiolini M, Bria M et al. Valutazione della secrezione dell'ormone della crescita (GH) in soggetti affetti da thalassemia major. Minerva Endocrinol 1993; 18 (Suppl. 1): 62-65.
24. Naim Shehadeh, Anna Hazani, Mary CJ et al. Neurosecretory dysfunction of growth hormone secretion in thalassemia major. Acta Pediatr Scand 1990; 79: 790-795.
25. Spiliotis BE, August GP, Hung W et al. Growth hormone neurosecretory dysfunction: a treatable cause of short stature. JAMA 1984; 251: 2223-2230.
26. De Simone M, Olioso P, Di Bartolomeo P et al. Growth and endocrine function following bone marrow transplantation for thalassemia. Bone Marrow Transplant 1995; 15: 227-233.
27. Wingard JR, Plotnick LP, Freemer CS et al. Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 1992; 79: 1068-1073.
28. Scacchi M, Danesi M, De Martin M et al. Treatment with biosynthetic growth hormone of short thalassaemic patients with impaired growth hormone secretion Clin Endocrinol 1991; 35: 335-339.